Parties
Full legal names and contact details for provider, patient, sponsor, and any third-party data processors.
A formal Healthcare Immune Protocol Agreement clarifies clinical roles, documents patient consent, and sets privacy and data use limits consistent with HIPAA and federal e-signature law, reducing legal ambiguity and operational risk.
Common users span clinical teams, research sponsors, institutional review boards, and patients or their authorized representatives.
Each signer’s role should be stated explicitly in the agreement so responsibilities, reporting lines, and signature authority are unambiguous.
Full legal names and contact details for provider, patient, sponsor, and any third-party data processors.
Clear description of therapies, dosages, monitoring schedules, inclusion/exclusion criteria, and escalation procedures.
Plain-language consent section describing risks, benefits, alternatives, and voluntary participation.
HIPAA-compliant data handling terms, permitted disclosures, retention, and de-identification requirements.
Reporting timelines, responsible parties, and required notifications to IRBs or regulators.
Allocation of risk, indemnification terms, and choice of state law to interpret the agreement.
| Field | Configuration |
|---|---|
| Signer Order | Set patient first, then provider, then sponsor |
| Authentication | Email + SMS code or institution SSO for staff |
| Conditional Fields | Show adverse-event reporting fields only if applicable |
| Retention | Enable secure PDF export and archive upon completion |
Use an e-signature platform that supports secure authentication, audit trails, and HIPAA-compliant workflows when PHI is present.
Platforms should support BAAs for HIPAA, role-based access, and integrations with EHRs or secure cloud storage to preserve chain-of-custody.
When signed; governs treatment window
Immediate for serious events; per IRB schedule
Respond within 30–60 days depending on state law
Annual or as-specified in agreement
See retention timeline; HIPAA minimum applies
Internal clinical and privacy approvals completed
Signed consent collected and timestamped
All required signatures obtained and recorded
Final PDF stored in EHR and secure archive
A clinic creates a protocol agreement to document immune-modulating adjunct therapy risks and monitoring
A university used a standardized agreement for multi-site immune research
The patient (adult with capacity) or a legally authorized representative signs to provide informed consent and authorize data use. For minors or incapacitated adults, include guardian or power-of-attorney documentation that demonstrates signing authority and legal basis.
A licensed clinician or designated institutional signatory (medical director, principal investigator, or named contracting officer) executes on behalf of the provider organization, confirming clinical oversight and operational responsibilities.
| signNow | DocuSign | Adobe Sign | PandaDoc | HelloSign | |
|---|---|---|---|---|---|
| Starting Price | $8/user/mo | $15/user/mo | $14/user/mo | $19/user/mo | $15/user/mo |
| Free Trial | 7-day free trial (no credit card) | Varies by vendor | Varies by vendor | Varies by vendor | Varies by vendor |
| Bulk Send | Yes (Business Premium) | Yes | Yes | Yes | No |
| Audit Trail | Yes | Yes | Yes | Yes | Yes |
| Envelope Cap | No envelope cap | 100 envelopes/user/year limit | Varies | Varies | Varies |